Nasdaq · Healthcare
SkinHealth Systems Inc. (SKIN)
As-reported financials and recent SEC filings for SkinHealth Systems Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$300.8M
Net income
$-9.5M
Net margin
-3.2%
Diluted EPS
$-0.16
ROE
-15.6%
P/E (TTM)
—
Market cap
$85.5M
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M |
| Gross profit | $196.4M | $182.3M | $155.1M | $248.8M | $178.5M |
| Operating income | $-20.8M | $-67.8M | $-130.9M | $-25.8M | $-39.9M |
| Net income | $-9.5M | $-29.1M | $-100.1M | $44.2M | $-378.8M |
| Diluted EPS | $-0.16 | $-0.36 | $-0.76 | $-0.23 | $-3.71 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-22
View on EDGAR →8-K2026-06-16
View on EDGAR →8-K/A2026-05-21
View on EDGAR →1442026-05-20
View on EDGAR →8-K2026-05-12
View on EDGAR →SCHEDULE 13D/A2026-05-11
View on EDGAR →10-Q2026-05-07
View on EDGAR →8-K2026-05-07
View on EDGAR →Go deeper on SKIN
Search SkinHealth Systems Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.